Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 21, 2016 (11 years ago)

0.9% Sodium Chloride Injection USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

Affected NDC 0338-0553-18

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sodium Chloride
NDC 00338-0553
900 mg/100mL Injection
Intravenous
Baxter Healthcare Corporation Rx
Recalling firm
Baxter Healthcare Corp.
NDC code
0338-0553-18
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0861-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Baxter Healthcare Corp.

All 2016 recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0718-12 D-0821-2026

Other sterility / contamination recalls from 2016

All sterility / contamination recalls
Class II · Moderate risk

AMGEN Kyprolis

Lack of Assurance of Sterility: Potential cracks in glass vials

Terminated Sterility / contamination Amgen, Inc. NDC 76075-102-01 D-0226-2017
Class I · High risk

Nano PNC Water

Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.

Terminated Sterility / contamination Pacific Medical Solutions D-0505-2017
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-6046-48 D-0206-2017